Asthma Clinical Trial
Official title:
To Deliver a Pilot Project on Effective Interventions to Ensure: Diagnostic Accuracy, Management of Risk and Control and Self-management for Asthma Patients.
Following on from a 10 year study conducted in Finland this study is designed to test the validity and sustainability of an enhanced asthma management model for the UK.
The British Lung Foundation (BLF) aims to work with the governments in the four UK nations
to launch an asthma initiative designed to improve asthma management and outcomes. The
project incorporates key learning from a 10 year programme in Finland designed to improve
asthma care and cap healthcare costs for paediatric and adult populations.
The Finland programme focused on accurate diagnosis, training and education of healthcare
professionals and patients and early use of anti-inflammatory therapy. The programme
successfully improved medication compliance, reduced asthma hospital admissions, reduced
asthma-related benefit claims and reduced the overall cost of asthma to the Finnish
Government.
To test the validity and sustainability of an enhanced asthma management model for the UK,
the BLF proposes to undertake a pilot initiative in England. The pilot will focus on:
improving diagnostic accuracy through analysis of GP asthma registers; increasing asthma
education among healthcare professionals; assessment of risk and control of patient's
asthma; supportive self-management and education of people with asthma.
It is anticipated that the pilot will lead to measureable and significant improvements in
asthma management, including:
- Reduced number of severe exacerbations (asthma hospitalisation, A&E attendance and oral
steroid rescue)
- Improved diagnostic accuracy (and reduction of diagnostic doubt)
- Improved implementation of recognised asthma guidelines, including appropriate step
wise management of patients
The pilot will also aim to increase the proportion of patients on the asthma register with
an asthma management plan and a recorded asthma control test therefore supporting higher
levels of control, and will promote peer-to-peer health care professional asthma education
and knowledge sharing to establish an asthma-training legacy.
The pilot model will be sustainable and reproducible across England and the devolved nations
(Scotland, Wales and Northern Ireland). Whilst the core aspects of an agreed national model
will be rolled out across the pilot site, it will be tailored and refined through local
collaboration (primary care, secondary care and commissioners) to help attain local targets
in line with regional differences, needs and priorities.
Results from the pilot will be reported 15 months after project initiation on site
(July/August 2014)
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
||
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|